UCSF

Topics and Expertise: QBI

UCSF School of Pharmacy leads in NIH funding for the 42nd straight year

Tue Feb 15, 2022
Ahituv and Inoue
Susan Merrell

Nadav Ahituv, PhD (right), works in his lab with postdoctoral researcher Fumitaka Inoue, PhD.

School research into health, disease, and medicine earned the most NIH research dollars of any U.S. pharmacy school for the 42nd consecutive year.

Map of protein systems reveals new targets for cancer treatment

Thu Dec 9, 2021
A branching network of protein systems
Krogan Lab

A birds-eye depiction of the findings from the Quantitative Biosciences Institute’s recent work on cancer. Each node represents a protein system and darker-colored nodes are more likely to be involved in cancer.

Scientists at the UCSF Quantitative Biosciences institute developed a new approach for understanding cancer and applied it to breast cancer and cancers of the neck and head

How cells multitask: the magic of molecular switches

Thu Oct 21, 2021
Kortemme
Elisabeth Fall

Tanja Kortemme, PhD

Research unearths new details about the protein networks that keep cells healthy

Cancer drug stops SARS-CoV-2 in the lab

Thu Feb 11, 2021
sea squirt.
PharmaMar

Aplidin is extracted from Aplidium albicans, a sea squirt found off the coast of Spain.

“If you get a drug that targets a human protein, it would be incredibly hard for the virus to mutate away from being reliant on it,” said Nevan Krogan, the director of QBI.

A genetic shortcut to help visualize proteins at work

Fri Dec 11, 2020

QBI probes three lethal coronaviruses to find possible drug targets

Fri Oct 23, 2020
Blue dots show MERS-CoV particles on the surface of a cell
National Institute of Allergy and Infectious Diseases (NIAID)

Middle East respiratory syndrome coronavirus (MERS-CoV) viral particles under an electron microscopic.

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

Fri Jul 10, 2020
Fraser
Elisabeth Fall

James Fraser, PhD

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

UCSF team has discovered drugs that block coronavirus, paving way for ‘a better drug sooner’

Thu May 7, 2020

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020
SARS-COV2 virus particles on human cells
NIH

SARS-COV2 virus particles (orange), which cause COVID-19, on human cells (blue). 

The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020
Krogan and Fabius

QBI’s director, Nevan Krogan, PhD, left, and Jacqueline Fabius, QBI's chief operating officer

The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.

Pages

Make a gift
Science is the foun­da­tion of the School of Pharmacy’s pi­o­neer­ing re­search, in­di­vid­ua­lized pa­tient care, and un­par­al­leled PharmD and PhD ed­u­ca­tion pro­grams.
© 2002–2022 The Regents of the University of California